Article
Transition from CSII to Second-Generation Basal Insulin Analogues in Hospitalized T2DM Patients: A CGM-Based Study
2026-02-09
Abstract excerpt
<title>Abstract</title> <p> Background The optimal approach for transitioning hospitalized patients with type 2 diabetes from continuous subcutaneous insulin infusion (CSII) to second-generation basal insulin analogues remains unclear. Methods This retrospective analysis included 135 patients transitioning from CSII to insulin degludec (IDeg, n = 77) or insulin glargine U300 (IGlar U300, n = 58), assessed by c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bac39e9a-b16b-5065-995f-dbdad836cef4
- DOI
- 10.21203/rs.3.rs-8712412/v1
